Mechanism of action of demethylating and immune modulatory agents - Discussion

被引：1
作者：
Hofmann, Wolf-K. [1 ]
机构：
[1] Univ Hosp, Dept Hematol & Oncol, D-68167 Mannheim, Germany
来源：
CANCER TREATMENT REVIEWS | 2011年 / 37卷
关键词：
MYELODYSPLASTIC SYNDROME; DELETION;
D O I：
10.1016/j.ctrv.2011.04.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S19 / S22
页数：4
相关论文
共 7 条
  • [1] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Finelli, Carlo
    Giagounidis, Aristoteles
    Schoch, Robert
    Gattermann, Norbert
    Sanz, Guillermo
    List, Alan
    Gore, Steven D.
    Seymour, John F.
    Bennett, John M.
    Byrd, John
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    [J]. LANCET ONCOLOGY, 2009, 10 (03) : 223 - 232
  • [2] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
    List, Alan
    Dewald, Gordon
    Bennett, John
    Giagounidis, Aristotle
    Raza, Azra
    Feldman, Eric
    Powell, Bayard
    Greenberg, Peter
    Thomas, Deborah
    Stone, Richard
    Reeder, Craig
    Wride, Kenton
    Patin, John
    Schmidt, Michele
    Zeldis, Jerome
    Knight, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) : 1456 - 1465
  • [3] Nolte F, 2010, FUTURE ONCOL, V6, P445, DOI [10.2217/fon.09.175, 10.2217/FON.09.175]
  • [4] Genome-wide DNA-mapping of CD34+cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy
    Nowak, Daniel
    Nolte, Florian
    Mossner, Maximilian
    Nowak, Verena
    Baldus, Claudia D.
    Hopfer, Olaf
    Noll, Stefanie
    Thiel, Eckhard
    Wagner, Florian
    Hofmann, Wolf-Karsten
    [J]. EXPERIMENTAL HEMATOLOGY, 2009, 37 (02) : 215 - 224
  • [5] Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
    Ramsay, Alan G.
    Clear, Andrew J.
    Kelly, Gavin
    Fatah, Rewas
    Matthews, Janet
    MacDougall, Finlay
    Lister, T. Andrew
    Lee, Abigail M.
    Calaminici, Maria
    Gribben, John G.
    [J]. BLOOD, 2009, 114 (21) : 4713 - 4720
  • [6] Myelodysplastic syndromes
    Zhou, Jiehao
    Orazi, Attilio
    Czader, Magdalena B.
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2011, 28 (04) : 258 - 272
  • [7] ZONDER JA, 2010, BLOOD
1